SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03 SinoMab BioScience Limited Nov 30, 2021 20:50 HKT/SGT Read More
Eisai and FCNT Enter Into Business Alliance Aiming to Support People Living with Dementia and to Prevent Dementia Eisai Nov 30, 2021 09:13 HKT/SGT Read More
Eisai to Present Latest Data on Perampanel and E2730 at the 75th American Epilepsy Society Annual Meeting Eisai Nov 30, 2021 08:56 HKT/SGT Read More
European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) for Patients With Certain Types of Endometrial Carcinoma Eisai Nov 29, 2021 11:44 HKT/SGT Read More
European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) as First-Line Treatment for Adult Patients With Advanced Renal Cell Carcinoma Eisai Nov 29, 2021 09:15 HKT/SGT Read More
Jacobson Pharma Announces FY2022 Interim Results Jacobson Pharma Corporation Limited Nov 26, 2021 19:39 HKT/SGT Read More
SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health SinoMab BioScience Limited Nov 26, 2021 18:26 HKT/SGT Read More
Inaugural Asia Summit on Global Health successfully explores healthcare landscape HKTDC Nov 25, 2021 20:00 HKT/SGT Read More
ACT Genomics and Sanomics Merge to Unleash Hong Kong's Global Potential in Healthcare Technology ACT Genomics Holdings Co., Ltd Nov 22, 2021 16:57 HKT/SGT Read More
휴머니젠, 3분기 및 2021년 9월 30일 종결되는 9개월간의 재무 결과 보고 및 기업보고서 발표 Humanigen, Inc. Nov 22, 2021 11:00 HKT/SGT Read More
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组 Apollomics, Inc. Nov 22, 2021 10:42 HKT/SGT Read More